Iqvia Holdings (IQV) Other Non-Current Assets (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Other Non-Current Assets came in at $489.0 million in Q1 2026, up 0.82% year-on-year from $485.0 million in Q1 2025, and down 3.17% quarter-over-quarter from $505.0 million in Q4 2025.
Iqvia Holdings (IQV) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $489.0 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $489.0 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $489.0 million (up 0.82% YoY), and the FY2025 annual result was $505.0 million, down 2.88% from the prior year.
- Other Non-Current Assets came in at $489.0 million for Q1 2026 at Iqvia Holdings, down from $505.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $528.0 million in Q1 2022 to a low of $435.0 million in Q2 2023.
- The 5-year median for Other Non-Current Assets is $478.0 million (2024), against an average of $482.3 million.
- Across the five-year window, Other Non-Current Assets surged 38.95% in 2022 and declined 11.36% in 2023, its largest moves.
- Iqvia Holdings' Other Non-Current Assets stood at $472.0 million in 2022, then declined by 3.6% to $455.0 million in 2023, then climbed by 14.29% to $520.0 million in 2024, then declined by 2.88% to $505.0 million in 2025, then decreased by 3.17% to $489.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $489.0 million (Q1 2026), $505.0 million (Q4 2025), and $474.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.18 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 489.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 454.16 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 256.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489.00 Mn |
| Dec 31, 2025 | 505.00 Mn |
| Sep 30, 2025 | 474.00 Mn |
| Jun 30, 2025 | 513.00 Mn |
| Mar 31, 2025 | 485.00 Mn |
| Dec 31, 2024 | 520.00 Mn |
| Sep 30, 2024 | 467.00 Mn |
| Jun 30, 2024 | 478.00 Mn |
| Mar 31, 2024 | 476.00 Mn |
| Dec 31, 2023 | 455.00 Mn |
| Sep 30, 2023 | 459.00 Mn |
| Jun 30, 2023 | 435.00 Mn |
| Mar 31, 2023 | 468.00 Mn |
| Dec 31, 2022 | 472.00 Mn |
| Sep 30, 2022 | 488.00 Mn |
| Jun 30, 2022 | 487.00 Mn |
| Mar 31, 2022 | 528.00 Mn |
| Dec 31, 2021 | 491.00 Mn |
| Sep 30, 2021 | 411.00 Mn |
| Jun 30, 2021 | 385.00 Mn |